• $83.5M
    Market Cap
  • -32.96%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
Cost of Revenue
9.7M
+63.79%
5.9M
N/A
Gross Profit
-9.7M
+63.79%
-5.9M
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-3.8M
+99.38%
-1.9M
N/A
Depreciation and Amortization Expense
287,961
+7.70%
267,382
N/A
Total Operating Expenses
15.7M
+57.33%
10.0M
N/A
Operating Profit
-9.7M
+63.79%
-5.9M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
Total Nonoperating Income and Expense
88,746
+1,398.60%
-6,834
N/A
Income before Taxes
-9.3M
+58.05%
-5.9M
N/A
Income Taxes
-105,205
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
Net Income from Continuing Operations Applicable to Common
-9.3M
+58.05%
-5.9M
N/A
Basic EPS and Net Income
-1.09
+22.47%
-0.89
N/A
Diluted EPS and Net Income
-1.09
+22.47%
-0.89
N/A
Basic Weighted Average Shares
8.4M
+27.70%
6.6M
N/A
Diluted Weighted Average Shares
8.4M
+27.70%
6.6M
N/A
Balance Sheet
Cash and Cash Equivalents
3.0M
-68.73%
9.7M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.0M
-68.73%
9.7M
N/A
Total Current Assets
3.9M
-63.59%
10.8M
N/A
Accumulated Depreciation
1.0M
+39.52%
728,701
N/A
Property and Plant and Equipment and Net
764,401
-13.38%
882,445
N/A
Total Long-Term Assets
764,401
-13.38%
882,445
N/A
Total Assets
6.0M
-54.19%
13.0M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
1.6M
+17.53%
1.3M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
942,940
-26.35%
1.3M
N/A
Total Liabilities
2.6M
-1.51%
2.6M
N/A
Retained Earnings
-21.1M
+76.67%
-11.9M
N/A
Total Stockholders Equity
3.4M
-67.40%
10.4M
N/A
Total Shares Outstanding
8.4M
+0.46%
8.4M
N/A
Cash Flow
Cash from Operating Activities
-6.5M
-23.56%
-8.5M
N/A
Capital Expenditures
169,917
-57.14%
396,451
N/A
Cash from Investing Activities
-150,218
-58.18%
-359,216
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
-27,709
-100.15%
18.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
2.51
N/A
N/A
N/A
Cash Ratio
1.94
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow